F.D.A. Panel’s Vote on Peptides Raises Concerns About a Prescribing Boom

Start
The committee endorsed broader use of the peptides in lightly regulated compounding pharmacies that have grown into a multibillion-dollar business.
Previous Story

Trump Administration Signs Contract for Long-Term National Guard Housing in D.C.

Next Story

How a Summer of War With Iran Could Shape the Fall Elections